Trade Summary

Yesterday, Sibold William John, serving as President and CEO at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 2,500 shares at $547.30 per share, for a total transaction value of $1,368,253.45. Following this transaction, Sibold William John now holds 209,329 shares of MDGL.

This sale represents a 1.18% decrease in Sibold William John's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, July 20, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 21, 2026 (accepted Jul 20, 9:16 PM ET), 1 day after the trade was made.

MADRIGAL PHARMACEUTICALS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.